Seach Medical Group Ltd (SEMG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Seach Medical Group Ltd (SEMG) has a cash flow conversion efficiency ratio of -0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-3.02 Million ≈ $-8.10K USD) by net assets (ILA107.49 Million ≈ $288.17K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Seach Medical Group Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Seach Medical Group Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Seach Medical Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Seach Medical Group Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Seach Medical Group Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nexus Minerals Ltd
AU:NXM
|
-0.347x |
|
DRC Systems India Limited
NSE:DRCSYSTEMS
|
0.019x |
|
OXE Marine AB
ST:OXE
|
-0.326x |
|
Stria Lithium Inc
V:SRA
|
-0.053x |
|
Zodiac Energy Limited
NSE:ZODIAC
|
-0.145x |
|
CodeMill AB
ST:CDMIL
|
0.052x |
|
SCI Electric Public Company Limited
BK:SCI
|
0.031x |
|
Next Entertainment World Co. Ltd
KQ:160550
|
0.005x |
Annual Cash Flow Conversion Efficiency for Seach Medical Group Ltd (2015–2024)
The table below shows the annual cash flow conversion efficiency of Seach Medical Group Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Seach Medical Group Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA102.94 Million ≈ $275.97K |
ILA16.29 Million ≈ $43.66K |
0.158x | +6158.10% |
| 2023-12-31 | ILA88.99 Million ≈ $238.58K |
ILA225.00K ≈ $603.22 |
0.003x | -98.52% |
| 2022-12-31 | ILA101.62 Million ≈ $272.43K |
ILA17.39 Million ≈ $46.63K |
0.171x | +301.28% |
| 2021-12-31 | ILA95.58 Million ≈ $256.24K |
ILA-8.13 Million ≈ $-21.79K |
-0.085x | -17.17% |
| 2020-12-31 | ILA79.25 Million ≈ $212.47K |
ILA-5.75 Million ≈ $-15.42K |
-0.073x | -509.90% |
| 2019-12-31 | ILA46.76 Million ≈ $125.36K |
ILA828.00K ≈ $2.22K |
0.018x | -87.73% |
| 2018-12-31 | ILA25.69 Million ≈ $68.87K |
ILA3.71 Million ≈ $9.94K |
0.144x | +155.80% |
| 2017-12-31 | ILA31.38 Million ≈ $84.12K |
ILA1.77 Million ≈ $4.75K |
0.056x | +132.72% |
| 2016-12-31 | ILA-3.64 Million ≈ $-9.75K |
ILA627.00K ≈ $1.68K |
-0.172x | -101.97% |
| 2015-12-31 | ILA-362.00K ≈ $-970.51 |
ILA-3.17 Million ≈ $-8.49K |
8.749x | -- |
About Seach Medical Group Ltd
Seach Medical Group Ltd manufactures and sells medicinal cannabis products worldwide. The company offers cannabis oil and medical cannabis inflorescence products. Seach Medical Group Ltd was founded in 2002 and is based in Ramat Gan, Israel.